BioNTech SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,870	2,751	3,819	17,311	18,977
Revenue Growth (YoY)	4.32%	-27.96%	-77.94%	-8.78%	3834.63%
Cost of Revenue	611.3	541.3	599.8	2,995	2,912
Gross Profit	2,259	2,210	3,219	14,316	16,065
Selling, General & Admin	624.4	599	557.7	541.2	327.2
Research & Development	2,105	2,254	1,783	1,537	949.2
Other Operating Expenses	796	642.1	-93.4	319.1	-57.7
Operating Expenses	3,525	3,495	2,247	2,397	1,219
Operating Income	-1,267	-1,286	971.8	11,918	14,847
Interest Expense	-14.2	-16.9	-7.5	-18.9	-27.3
Interest & Investment Income	262.6	437.6	330.9	-	1.5
Currency Exchange Gain (Loss)	-97.3	100.4	-267.9	792.4	512.5
Other Non Operating Income (Expenses)	151	200.4	161.5	265.3	-277.8
EBT Excluding Unusual Items	-964.6	-564	1,189	12,957	15,055
Gain (Loss) on Sale of Investments	3.1	-	26.7	-	-
Asset Writedown	-30.5	-	-	-	-
Legal Settlements	-73.8	-113.7	-29.4	-3	-9
Other Unusual Items	15	-	-	-	-
Pretax Income	-1,051	-677.7	1,186	12,954	15,046
Income Tax Expense	85.3	-12.4	255.8	3,520	4,754
Earnings From Continuing Operations	-1,136	-665.3	930.3	9,434	10,293
Net Income to Company	-1,136	-665.3	930.3	9,434	10,293
Net Income	-1,136	-665.3	930.3	9,434	10,293
Net Income to Common	-1,136	-665.3	930.3	9,434	10,293
Net Income Growth	-	-	-90.14%	-8.34%	67613.82%
Shares Outstanding (Basic)	242	240	241	243	244
Shares Outstanding (Diluted)	242	240	243	250	260
Shares Change (YoY)	0.54%	-0.95%	-2.84%	-3.81%	4.51%
EPS (Basic)	-4.70	-2.77	3.87	38.78	42.18
EPS (Diluted)	-4.70	-2.77	3.83	37.77	39.63
EPS Growth	-	-	-89.86%	-4.69%	65950.00%
Free Cash Flow	280.9	-78.8	5,121	13,248	762.2
Free Cash Flow Per Share	1.16	-0.33	21.10	53.03	2.94
Gross Margin	78.70%	80.32%	84.29%	82.70%	84.66%
Operating Margin	-44.14%	-46.73%	25.45%	68.85%	78.23%
Profit Margin	-39.59%	-24.18%	24.36%	54.50%	54.24%
Free Cash Flow Margin	9.79%	-2.86%	134.10%	76.53%	4.02%
EBITDA	-1,124	-1,175	1,110	11,983	14,893
EBITDA Margin	-39.17%	-42.69%	29.07%	69.22%	78.48%
D&A For EBITDA	142.6	111	138.2	64.5	46.2
EBIT	-1,267	-1,286	971.8	11,918	14,847
EBIT Margin	-44.14%	-46.73%	25.45%	68.85%	78.23%
Effective Tax Rate	-	-	21.57%	27.17%	31.60%
Revenue as Reported	-	-	-	-	18,977

Updated Mar 10, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q